467 related articles for article (PubMed ID: 38328427)
1. Otitis media: recent advances in otitis media vaccine development and model systems.
Zahid A; Wilson JC; Grice ID; Peak IR
Front Microbiol; 2024; 15():1345027. PubMed ID: 38328427
[TBL] [Abstract][Full Text] [Related]
2. Otopathogens in the middle ear and nasopharynx of children with recurrent acute otitis media.
Ruttkay Pereira DR; Pereira MR; Rotta Pereira MB; Costa SS; Mott MP; Cantarelli V
Int J Pediatr Otorhinolaryngol; 2023 Jun; 169():111552. PubMed ID: 37120991
[TBL] [Abstract][Full Text] [Related]
3. Bacterial otitis media: current vaccine development strategies.
Cripps AW; Kyd J
Immunol Cell Biol; 2003 Feb; 81(1):46-51. PubMed ID: 12534945
[TBL] [Abstract][Full Text] [Related]
4. Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era.
Pumarola F; Marès J; Losada I; Minguella I; Moraga F; Tarragó D; Aguilera U; Casanovas JM; Gadea G; Trías E; Cenoz S; Sistiaga A; García-Corbeira P; Pirçon JY; Marano C; Hausdorff WP
Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1231-6. PubMed ID: 23746414
[TBL] [Abstract][Full Text] [Related]
5. Panel 8: Vaccines and immunology.
Alderson MR; Murphy T; Pelton SI; Novotny LA; Hammitt LL; Kurabi A; Li JD; Thornton RB; Kirkham LS
Int J Pediatr Otorhinolaryngol; 2020 Mar; 130 Suppl 1(Suppl 1):109839. PubMed ID: 31948716
[TBL] [Abstract][Full Text] [Related]
6. New vaccines against otitis media: projected benefits and cost-effectiveness.
O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
[TBL] [Abstract][Full Text] [Related]
7. What is behind the ear drum? The microbiology of otitis media and the nasopharyngeal flora in children in the era of pneumococcal vaccination.
Mills N; Best EJ; Murdoch D; Souter M; Neeff M; Anderson T; Salkeld L; Ahmad Z; Mahadevan M; Barber C; Brown C; Walker C; Walls T
J Paediatr Child Health; 2015 Mar; 51(3):300-6. PubMed ID: 25175818
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.
Prymula R; Peeters P; Chrobok V; Kriz P; Novakova E; Kaliskova E; Kohl I; Lommel P; Poolman J; Prieels JP; Schuerman L
Lancet; 2006 Mar; 367(9512):740-8. PubMed ID: 16517274
[TBL] [Abstract][Full Text] [Related]
9. Haemophilus influenzae type b as an important cause of culture-positive acute otitis media in young children in Thailand: a tympanocentesis-based, multi-center, cross-sectional study.
Intakorn P; Sonsuwan N; Noknu S; Moungthong G; Pirçon JY; Liu Y; Van Dyke MK; Hausdorff WP
BMC Pediatr; 2014 Jun; 14():157. PubMed ID: 24947736
[TBL] [Abstract][Full Text] [Related]
10. Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review.
Ngo CC; Massa HM; Thornton RB; Cripps AW
PLoS One; 2016; 11(3):e0150949. PubMed ID: 26953891
[TBL] [Abstract][Full Text] [Related]
11. Middle ear secretory capacity after acute otitis media caused by Streptococcus pneumoniae, Moraxella catarrhalis, non-typeable or type B Haemophilus influenzae. A comparative analysis based on goblet cell density.
Cayé-Thomasen P; Hermansson A; Tos M; Prellner K
Acta Otolaryngol Suppl; 2000; 543():54-5. PubMed ID: 10908976
[TBL] [Abstract][Full Text] [Related]
12. BIGDATA: A Protocol to Create and Extend a 25-Year Clinical Trial and Observational Data Asset to Address Key Knowledge Gaps in Otitis Media and Hearing Loss in Australian Aboriginal and Non-Aboriginal Children.
Beissbarth J; Smith-Vaughan HC; Cheng AC; Morris PS; Leach AJ
Front Pediatr; 2022; 10():804373. PubMed ID: 35498792
[TBL] [Abstract][Full Text] [Related]
13. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines.
Leach AJ; Wigger C; Beissbarth J; Woltring D; Andrews R; Chatfield MD; Smith-Vaughan H; Morris PS
Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():224-32. PubMed ID: 27260611
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal vaccine impact on otitis media microbiology: A New Zealand cohort study before and after the introduction of PHiD-CV10 vaccine.
Best EJ; Walls T; Souter M; Neeff M; Anderson T; Salkeld L; Ahmad Z; Mahadevan M; Walker C; Murdoch D; Mills N
Vaccine; 2016 Jul; 34(33):3840-7. PubMed ID: 27265454
[TBL] [Abstract][Full Text] [Related]
15. Adaptive bone modeling and remodeling in acute otitis media caused by non-typeable or type B Haemophilus influenzae or Moraxella catarrhalis.
Cayé-Thomasen P; Tos M
Acta Otolaryngol; 2000 Oct; 120(7):815-20. PubMed ID: 11132713
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal conjugate vaccine for young children.
Selman S; Hayes D; Perin LA; Hayes WS
Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
[TBL] [Abstract][Full Text] [Related]
17. A prospective, observational, epidemiological evaluation of the aetiology and antimicrobial susceptibility of acute otitis media in Saudi children younger than 5years of age.
Al-Mazrou KA; Shibl AM; Kandeil W; Pirçon JY; Marano C
J Epidemiol Glob Health; 2014 Sep; 4(3):231-8. PubMed ID: 25107659
[TBL] [Abstract][Full Text] [Related]
18. Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany.
van der Linden M; Imöhl M; Busse A; Rose M; Adam D
Eur J Pediatr; 2015 Mar; 174(3):355-64. PubMed ID: 25169065
[TBL] [Abstract][Full Text] [Related]
19. Genetic similarity between adenoid tissue and middle ear fluid isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis from Iranian children with otitis media with effusion.
Emaneini M; Gharibpour F; Khoramrooz SS; Mirsalehian A; Jabalameli F; Darban-Sarokhalil D; Mirzaii M; Sharifi A; Taherikalani M
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1841-5. PubMed ID: 24080321
[TBL] [Abstract][Full Text] [Related]
20. Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial.
Beissbarth J; Wilson N; Arrowsmith B; Binks MJ; Oguoma VM; Lawrence K; Llewellyn A; Mulholland EK; Santosham M; Morris PS; Smith-Vaughan HC; Cheng AC; Leach AJ
Vaccine; 2021 Apr; 39(16):2264-2273. PubMed ID: 33766422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
